Nyxoah SA

Nyxoah SA (NYXH) priced its initial public offering on Jul 6, 2021 at $30.00 per share, and listed on Nasdaq Global Market. At the IPO price its market capitalization was about $748.3M. Piper Sandler was lead-left underwriter, joined by Stifel and Cantor. Mintz and Latham & Watkins advised the underwriters.

Nyxoah SA is a medical technology company focused on obstructive sleep apnea. Its Genio system is a CE-marked bilateral hypoglossal nerve stimulation device that has generated revenue in Europe since July 2020, while a pivotal trial supports U.S. marketing authorization.

Status

IPO

Ticker

NYXH

Exchange

Nasdaq Global Market

Priced

Jul 6, 2021

IPO price

$30.00

Market cap at IPO price

$748.3M

First filed

Jun 10, 2021

Underwriters

Piper Sandler, Stifel and Cantor

Underwriters' counsel

Mintz and Latham & Watkins

Sector

Healthcare

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.